Urticaria after methyl aminolevulinate photodynamic therapy in a patient with nevoid basal cell carcinoma syndrome.

Christopher M Wolfe, W Harris Green, H Keith Hatfield, Armand B Cognetta

Lake Erie College of Osteopathic Medicine, Erie, PA, USA. wolfe1pa@gmail.com

Journal of drugs in dermatology : JDD 2012 Nov

filter terms:

Methyl aminolevulinate photodynamic therapy (MAL-PDT) is utilized in several countries for the treatment of basal cell carcinoma, but allergic sensitization has been reported by the manufacturer. To the best of our knowledge, we report the first case of urticaria following MAL-PDT in a patient with nevoid basal cell carcinoma syndrome. Prophylactic use of antihistamines may allow continued use of MAL-PDT in this setting.

Citation

Christopher M Wolfe, W Harris Green, H Keith Hatfield, Armand B Cognetta. Urticaria after methyl aminolevulinate photodynamic therapy in a patient with nevoid basal cell carcinoma syndrome. Journal of drugs in dermatology : JDD. 2012 Nov;11(11):1364-5